Empowering drug development: Leveraging insights from imaging technologies to enable the advancement of digital health technologies

The US Food and Drug Administration (FDA) has publicly recognized the importance of improving drug development efficiency, deeming translational biomarkers a top priority. The use of imaging biomarkers has been associated with increased rates of drug approvals. An appropriate level of validation pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Izmailova, Elena S., Maguire, R. Paul, McCarthy, Timothy J., Müller, Martijn L. T. M., Murphy, Philip, Stephenson, Diane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014695/
https://www.ncbi.nlm.nih.gov/pubmed/36382716
http://dx.doi.org/10.1111/cts.13461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014695/
https://www.ncbi.nlm.nih.gov/pubmed/36382716
http://dx.doi.org/10.1111/cts.13461

Ejemplares similares